Heart disease risks experienced in childhood impact cognition later in life

May 01, 2017

Cardiovascular risk factors such as high blood pressure, cholesterol and smoking have long been associated with cognitive deficiencies in adults. A new study, published today in the Journal of the American College of Cardiology, found the burden of cardiovascular risk factors from childhood and adolescence is associated with worse midlife cognition regardless of adulthood exposure.

"While it is well known that high blood pressure, cholesterol and smoking are associated with poor cognitive performance in adults, the effects of these risk factors from childhood on midlife cognition were unknown," said Suvi Rovio, PhD, senior scientist at the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku in Turku, Finland, and the study's lead author.

Researchers analyzed data from the Cardiovascular Risk in Young Finns Study, which has followed a population-based sample of 3,596 individuals from childhood to adulthood since 1980. As part of the 31-year follow-up, cognitive testing was performed as well as regular measurement of blood pressure, cholesterol, triglycerides, body mass index and smoking exposure. These continuous risk variables were evaluated to indicate the long-term burden of each measurement. They were defined separately for childhood (6-12 years), adolescence (12-18 years), young adulthood (18-24 years) and early life (6-24 years).

The Young Finns Study also analyzes age, sex, baseline household income, blood pressure and cholesterol medications, diagnoses of heart disease and Type 1 and Type 2 diabetes. Altogether, 1,901 individuals with cognitive test data had complete data on the other variables analyzed.

The study found that high blood pressure and high cholesterol in childhood, adolescence and young adulthood, as well as smoking in adolescence and young adulthood were associated with worse midlife cognitive performance, especially memory and learning. Study participants with all risk factors within recommended levels between ages 6-24 performed better on cognitive testing than those exceeding all risk factor guidelines at least twice. In all, the difference corresponded to the effect of six years of aging.

Researchers also looked at the independent effects of early life cumulative burden of high blood pressure, high cholesterol, BMI and smoking on cognitive performance. Individuals with the highest blood pressure had an 8.4 years' difference in cognitive age compared to individuals with the lowest blood pressure. Similarly, researchers found a 6.6 years difference between those with high and low cholesterol and a 3.4 years difference between smokers and non-smokers.

"These findings support the need for active monitoring and treatment strategies against cardiovascular risk factors from childhood," Rovio said. "This shouldn't just be a matter of cognitive deficits prevention, but one of primordial prevention."

Study limitations included that cognitive performance was measured once over the course of the Young Finns Study. This prevented researchers from determining the role of early life cardiovascular risk factors on changes in cognition.

"Recent evidence has demonstrated that risk factors developed in adulthood can impact cognitive dysfunction in the elderly, if they have not been corrected," said Valentin Fuster, MD, PhD, MACC, editor-in-chief of the Journal of the American College of Cardiology. "The findings in this paper are important, because they show that risk factors that develop at an even younger age can have the same adverse impact."

In an accompanying editorial, Donald M. Lloyd-Jones, MD, ScM, and Norrina B. Allen, PhD, MPH, from the Feinberg School of Medicine at Northwestern University in Chicago, said, "These findings extend our prior understanding on the accumulation of CV risk and cognition back into childhood and suggest that the adverse impacts on later-life health begin accruing very early in life."
The American College of Cardiology is the professional home for the entire cardiovascular care team. The mission of the College and its more than 52,000 members is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit acc.org.

The Journal of the American College of Cardiology is the most widely read cardiovascular journal in the world and is the top ranked cardiovascular journal for its scientific impact. JACC is the flagship for a family of journals that publish peer-reviewed research on all aspects of cardiovascular disease. JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging and JACC: Heart Failure also rank among the top ten cardiovascular journals for impact. JACC: Clinical Electrophysiology and JACC: Basic to Translational Science are the newest journals in the JACC family. Learn more at JACC.org.

American College of Cardiology

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.